Zura Bio (ZURA) Return on Capital Employed (2022 - 2026)
Zura Bio's (ZURA) quarterly Return on Capital Employed came in at 51.08% in Q1 2026, down 843.0% year-on-year from 6.87% in Q1 2025, and up 20.9% quarter-over-quarter from 64.57% in Q4 2025.
Zura Bio (ZURA) Return on Capital Employed (2022 - 2026) Analysis & Trends
Zura Bio's Return on Capital Employed history runs 5 years deep, the most recent figure standing at 51.08% for Q1 2026.
- On a quarterly basis, Return on Capital Employed fell 843.0% year-over-year to 51.08% in Q1 2026; TTM through Mar 2026 was 51.08%, a 843.0% decrease from a year earlier, with the FY2025 full-year figure at 56.02%, down 1028.0% from the prior year.
- Return on Capital Employed grew to 51.08% in Q1 2026 per ZURA's latest filing, from 64.57% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 29.4% in Q3 2024 and bottomed at 136.47% in Q1 2023.
- The 5-year median for Return on Capital Employed is 54.48% (2025), against an average of 62.57%.
- Across the five-year window, Return on Capital Employed surged 6896 bps in 2024 and sank 3108 bps in 2025, its largest moves.
- Year by year, Return on Capital Employed stood at 46.79% in 2022, then sank by 62 bps to 76.0% in 2023, then jumped by 56 bps to 33.49% in 2024, then sank by 93 bps to 64.57% in 2025, then advanced by 21 bps to 51.08% in 2026.
- Per Business Quant, the three latest ZURA Return on Capital Employed figures stand at 51.08% (Q1 2026), 64.57% (Q4 2025), and 57.88% (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -31.80% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 10.46% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -68.47% |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 21.10% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 10.19% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -68.84% |
| 10 | Zura Bio | 593.66 Mn | 593.66 Mn | - | -51.08% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -51.08% |
| Dec 31, 2025 | -64.57% |
| Sep 30, 2025 | -57.88% |
| Jun 30, 2025 | -49.41% |
| Mar 31, 2025 | -42.64% |
| Dec 31, 2024 | -33.49% |
| Sep 30, 2024 | -29.40% |
| Jun 30, 2024 | -32.94% |
| Mar 31, 2024 | -78.16% |
| Dec 31, 2023 | -76.00% |
| Sep 30, 2023 | -75.21% |
| Jun 30, 2023 | -101.90% |
| Mar 31, 2023 | -136.47% |
| Dec 31, 2022 | -46.79% |